SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001038133-20-000084
Filing Date
2020-11-18
Accepted
2020-11-18 15:13:21
Documents
16
Period of Report
2020-11-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hska-20201118.htm   iXBRL 8-K 42889
7 LOGO heskalogoa051.jpg GRAPHIC 45126
8 EX-99.1 ANTIN APPOINTMENT ex991antinappointment.htm EX-99.1 11106
  Complete submission text file 0001038133-20-000084.txt   270415

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hska-20201118.xsd EX-101.SCH 2415
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hska-20201118_cal.xml EX-101.CAL 708
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hska-20201118_def.xml EX-101.DEF 1645
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hska-20201118_lab.xml EX-101.LAB 23970
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hska-20201118_pre.xml EX-101.PRE 12644
9 EXTRACTED XBRL INSTANCE DOCUMENT hska-20201118_htm.xml XML 19054
Mailing Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538
Business Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 9704937272
HESKA CORP (Filer) CIK: 0001038133 (see all company filings)

IRS No.: 770192527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22427 | Film No.: 201324631
SIC: 2835 In Vitro & In Vivo Diagnostic Substances